
Medicinal CBD products can be legally obtained in Australia from a pharmacy, with a prescription from a registered doctor or nurse practitioner who considers it clinically appropriate. A pharmacist-only pathway for approved low-dose CBD also exists in law, but no product currently meets those criteria, so availability always comes down to the specific product and its approvals.
(If you're still fuzzy on the difference between CBD gummies and the hemp seed gummies sold freely in supplement shops, start with our explainer Hemp Gummies vs CBD Gummies in Australia: What's Actually in the Jar? — it matters for everything below.)
The Starting Point: CBD Is a Medicine, Not a Supplement
In Australia, cannabidiol sits in the Poisons Standard as a therapeutic substance, which puts it under the Therapeutic Goods Administration (TGA) rather than food law. That's the opposite of countries like the US or UK, where CBD is often sold as a wellness supplement. In practice, an unapproved medicinal CBD product reaches you legally through a prescription from a registered doctor or nurse practitioner, with supply permitted only where the TGA's access framework — and sometimes state or territory approval — covers that particular product. That is why legality is assessed product by product rather than assumed for CBD gummies generally.
One consequence worth knowing: most prescribed cannabis products in Australia are technically "unapproved" medicines. Of more than 1,000 medicinal cannabis products available by prescription, only two — Epidyolex (a CBD liquid for severe epilepsy) and Sativex (a THC/CBD mouth spray for MS spasticity) — have gone through full TGA pre-market evaluation for quality, safety and efficacy Monash University. The rest are supplied because a prescriber has been authorised to use them, not because the TGA has endorsed them. That's legal and common — but it makes independent lab reports and reputable brands more important, not less.
Pathway 1: A Prescription Through Your Own GP
A registered doctor or nurse practitioner may prescribe medicinal cannabis, including CBD, when they consider it clinically appropriate. Your GP is a reasonable place to start that conversation. Because most CBD products are unapproved, they generally need the relevant TGA approval — and sometimes state or territory approval — before a pharmacy can dispense them, so no particular gummy can be assumed to be available.
In practice, many GPs are still cautious or unfamiliar with the process. If yours isn't comfortable prescribing, that's not a dead end — it's a referral. You can also ask whether they'd be willing to prescribe in consultation with a specialist or a cannabis-informed clinic, which some GPs prefer.
Pathway 2: Telehealth Cannabis Clinics
The biggest change in Australian access over the past few years has been the rise of telehealth clinics specialising in medicinal cannabis. The process typically looks like this:
- Book an initial consultation — usually $50–$150, often with a nurse screening call first The Cannabis Shop AU.
- Consult with a doctor who assesses your condition, history and current medications, then decides whether a cannabis product is clinically appropriate.
- The clinic handles the TGA paperwork (more on that below) and sends the prescription to a partner pharmacy.
- The pharmacy dispenses and posts the product to your door. Follow-up consults review your response and adjust dosing.
Total running costs vary by product and dose, but current market guides put medication costs at roughly $2–$15 per day, with prescribed edibles like gummies commonly landing around $100–$150 for a 30-piece pack, plus consultation fees Medio. Medicinal cannabis is not currently PBS-subsidised for most conditions, so this is an out-of-pocket expense — worth factoring in honestly before you start.
A word of caution the regulators have been repeating: access has grown explosively, and prescription patterns have shifted toward high-THC products, which now account for a large share of prescribing — with half of voluntary adverse event reports to the TGA over a recent three-year period relating to higher-THC products Monash University. The TGA has flagged medicinal cannabis as a compliance priority for 2026 and ran a public consultation on the safety oversight of unapproved products in late 2025, so expect the rules around prescribing and product standards to keep tightening TGA. None of this affects the legality of a legitimate prescription — but it's a good reason to choose clinics that take assessment seriously rather than those that feel like a rubber stamp.
Pathway 3: Over the Counter — The Rule That Exists but the Products Don't
You may have read that low-dose CBD was "legalised over the counter" in Australia. Here's what actually happened: in 2021, the TGA down-scheduled low-dose CBD (up to 150 mg per day, adults only) from Schedule 4 (prescription-only) to Schedule 3 (pharmacist-only). That created a legal shelf for over-the-counter CBD at pharmacies — but only for products formally approved and listed on the Australian Register of Therapeutic Goods (ARTG).
As of October 2026, the TGA's position still stands: no products have been approved and registered under the Schedule 3 criteria, so there is nothing on that shelf TGA. The pathway exists; the products don't. If a pharmacy, supplement shop or website offers you CBD gummies with no prescription, they are not operating within this framework — full stop. If the Schedule 3 pathway matters to your decision, check the TGA's Australian Register of Therapeutic Goods for the current status of low-dose CBD products before assuming one is available. The register is the authoritative source on whether a product has been approved for pharmacist-only supply.
What the SAS and AP Acronyms Mean (In One Minute)
You'll see these everywhere, so here's the plain version:
- Special Access Scheme (SAS): the TGA mechanism that lets a doctor prescribe an unapproved medicine for an individual patient. Most medicinal cannabis in Australia reaches patients this way. Applications are submitted online and, for most prescribers using standard categories, processed quickly.
- Authorised Prescriber (AP): approval for a doctor to prescribe a particular unapproved product to a whole class of patients without applying case-by-case each time. Specialist cannabis clinics typically operate this way.
You don't need to do anything with either of these — your prescriber handles them. They're worth recognising mainly so that when a clinic mentions "SAS approval," you know it's routine, not a special favour.
What About Importing CBD Gummies Yourself?
This is the trap that catches the most people, so let's be direct: buying CBD gummies from an overseas website and having them posted to Australia is not a legal shortcut.
Australia's Personal Importation Scheme — which does let people bring in small quantities of some unapproved medicines — expressly excludes cannabis-containing products except under the narrow traveller's exemption. That exemption applies to a patient physically carrying their own prescribed medicine into the country for personal use, not to mail-order purchases TGA.
Practically, this means an overseas CBD order can be seized at the border, and the buyer carries the legal risk — "the website shipped it" is not a defence. Our guide to lab reports and red flags covers what verification should look like.
Do the Rules Differ Between States and Territories?
The national TGA framework governs access to medicinal cannabis across Australia, but state and territory rules can also affect what may be prescribed and supplied. Driving and workplace implications differ between jurisdictions too, so it is worth checking the rules where you live before relying on a prescription elsewhere.
- Driving. Most jurisdictions have zero-tolerance roadside drug testing, and a prescription has historically been no defence to a "presence" offence for THC. That's now shifting: NSW passed the Road Transport Legislation Amendment (Medical Cannabis and Driving Offences) Bill 2026 on 17 September 2026, creating a medical defence for prescribed patients who test positive below a set threshold — though the change has not yet commenced, and driving while impaired remains an offence everywhere Transport for NSW ABC News. If you use CBD-only products (isolate or broad spectrum with non-detectable THC), roadside THC testing is generally not your problem — but full-spectrum products contain trace THC, so check your product's lab report and your state's rules.
- Workplace policies. A prescription doesn't override an employer's drug policy. Some workplaces test and some contracts treat any detectable cannabinoid as a breach, regardless of legality Coleman Greig Lawyers. If your job involves testing, raise it with your prescriber and check your policy before starting.
So What's the Sensible Sequence?
Before buying, separate an Australian prescription product from an overseas checkout page. International mail-order CBD can look simple, but it is not a safe legal shortcut and may leave you without the access arrangement you assumed you had. If CBD gummies seem appropriate, the practical next step is a clinician discussion followed by pharmacy dispensing through a recognised Australian pathway.
This article is general information — not medical or legal advice. Cannabis regulation in Australia is actively changing; verify current rules with the TGA and your prescriber before acting.
Sources and last checked: 24 October 2026
- TGA — Over-the-counter access to low dose cannabidiol (Schedule 3 status; no ARTG-registered products): tga.gov.au/news/media-releases/over-counter-access-low-dose-cannabidiol
- TGA — Medicinal cannabis hub: access pathways, patient information, importation and traveller's exemption: tga.gov.au
- TGA — Planned consultation on unapproved medicinal cannabis products (published 4 August 2025): tga.gov.au
- Monash University / Drug and Alcohol Review (2026) — Prescription access trends and safety data: monash.edu
- Transport for NSW — Medical cannabis and driving (Bill passed 17 Sept 2026, not yet commenced): transport.nsw.gov.au
- ABC News (4 June 2026) — NSW medicinal cannabis driving reforms: abc.net.au
- Medio — 2026 medical cannabis cost guide: medio.com.au
- The Cannabis Shop AU — consultation fee ranges: thecannabisshopau.com
- Coleman Greig — Medical cannabis in the workplace: cgw.com.au